Safety and Ergogenic Properties of Combined Aminophylline and Ambrisentan in Hypoxia
Open Access
- 17 October 2017
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 103 (5) , 888-898
Abstract
We hypothesized that concomitant pharmacological inhibition of the endothelin and adenosine pathway is safe and improves exercise performance in hypoxic humans, via a mechanism that does not involve augmentation of blood oxygenation. To test this hypothesis, we established safety and drug interactions for aminophylline (500 mg) plus ambrisentan (5 mg) in normoxic volunteers. Subsequently, a placebo‐controlled study was employed to test the combination in healthy resting and exercising volunteers at simulated altitude (4,267 m). No serious adverse events occurred. Drug interaction was minimal or absent. Aminophylline alleviated hypoxia‐induced headaches. Aminophylline, ambrisentan, and their combination all significantly (P < 0.05 vs. placebo) improved submaximal hypoxic exercise performance (19.5, 20.6, and 19.1% >placebo). Single‐dose ambrisentan increased blood oxygenation in resting, hypoxic subjects. We conclude that combined aminophylline and ambrisentan offer promise to safely increase exercise capacity in hypoxemic humans without relying on increasing blood oxygen availability.Keywords
Funding Information
- US DARPA and ONR (#66001-10-C-2134, #N0014-14-0699)
- NCATS/NIH (#UL1TR001117)
This publication has 42 references indexed in Scilit:
- Sympathetic inhibition attenuates hypoxia induced insulin resistance in healthy adult humansThe Journal of Physiology, 2012
- Effect of hypohydration and altitude exposure on aerobic exercise performance and acute mountain sicknessJournal of Applied Physiology, 2010
- Physiological Adaptation of the Cardiovascular System to High AltitudeProgress in Cardiovascular Diseases, 2010
- Prevention and Treatment of High-Altitude Pulmonary EdemaProgress in Cardiovascular Diseases, 2010
- Effect of Altitude on the Heart and the LungsCirculation, 2007
- Endothelin-1-mediated vasoconstriction at rest and during dynamic exercise in healthy humansAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Influences of adenosine receptor antagonism on vasodilator responses to adenosine and exercise in adenosine responders and nonrespondersJournal of Applied Physiology, 2006
- Adenosine and muscle vasodilatation in acute systemic hypoxiaActa Physiologica Scandinavica, 2000
- Theophylline improves acute mountain sicknessEuropean Respiratory Journal, 2000
- Limiting factors for exercise at extreme altitudesClinical Physiology and Functional Imaging, 1990